Company Details
OPX Biotechnologies
2425 55th Street Suite 100, Boulder, CO, 80301, United States
Overview
OPX Biotechnologies develops renewable bio-based chemicals and fuels using its proprietary EDGE™ (Efficiency Directed Genome Engineering) technology. Its lead product is BioAcrylic, a renewable alternative to petroleum-derived acrylic used in diapers, detergents, paints and adhesives. The company is also developing a diesel fuel produced from carbon dioxide and hydrogen. OPXBIO intends to commercialize an industrial-scale process for BioAcrylic and accelerate development with new financing. The company is led by president and CEO Charles R. (Chas) Eggert and is based in Boulder, Colorado.
- Total raised
- $37M
- Funding rounds
- 1
- Latest round
- Series C
- Latest activity
- Jul 2011
Industries
- Biofuel
- Biotechnology
- Clean Energy
Recent funding
Series C
Jul 2011
$37M
Team
No current team members are available.